Hemepoietin with Cofactors Suppositories - 30 Count

Hemepoietin with Cofactors Suppositories - 30 Count | Zetpil
formerly Ferrosorb

This item is not returnable

Usual adult dosage is 1 suppository daily, or as directed by physician.

Contraindications: This product is contraindicated in patients with a know hypersensitivity to any of the ingredients. Patients sensitive to phospholipids should not take this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.

Warnings:

Folic acid alone is improper treatment in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient and not administered constantly. Ferrosorb contains both Folic acid in the more bioactive form Folinic Acid and B12 in the metabolically active forms of Methylcobalamin and Cobamamide.

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under the age 6 years old. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions:

The type of anemia and the underlying cause or causes should be determined before starting therapy with Ferrosorb. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.

Folic Acid: Allergic sensitization, including anaphylactoid reactions including urticaria (itching) has been reported following the administration and of both oral and parenteral folinic acid. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia. Pediatric Use: Safety and effectiveness in pediatric patients have not been established.

Geriatric Use: Clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Adverse Reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, darks stools and abdominal pain. Adverse reactions with iron therapy are usually transient. Allergic sensitization has rarely been reported following both oral and parenteral administration of folic acid

Overdosage: The clinical course of acute iron over dosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

Reviews